Search
Syndax Pharmaceuticals Inc
SNDXAdd to Watchlist
20.810USD
-0.400-1.89%
Close 07-24 16:00（ET）Quotes delayed by 15 min
1.82BMarket Cap
LossP/E TTM
Syndax Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of Syndax Pharmaceuticals Inc is 7.45, ranking 233 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.45, which is -69.88% below the recent high of -2.24 and -58.30% above the recent low of -11.79.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.